Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors
I'm PortAI, I can summarize articles.
Corbus Pharmaceuticals Holdings Inc. (CRBP) stock fell 2.27% to $9.48 on Monday, underperforming compared to some competitors. The NASDAQ Composite Index and Dow Jones Industrial Average also declined. CRBP is 53.89% below its 52-week high of $20.56. In contrast, Vanda Pharmaceuticals Inc. (VNDA) rose 6.42%, and Fortress Biotech Inc. (FBIO) increased 13.31%, while Viking Therapeutics Inc. (VKTX) fell 2.51%. Data was compiled on December 15, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments